INTRODUCTION {#SEC1}
============

The pivotal roles of the *Hox* genes in metazoan embryonic development have long been recognized. However, the regulation of the *Hox* genes themselves is not well understood, especially in vertebrates. At early developmental stages, all of the *Hox* genes are repressed. In mouse embryonic stem cells (mESCs), all four repressed *Hox* gene clusters possess both the active histone modification H3K4me3 and the repressive histone modification H3K27me3, which is referred to as a bivalent chromatin state ([@B1]). Recent studies showed that each repressed *Hox* gene cluster is packaged into a small topologically associated domain (TAD) ([@B2]). During activation of the *Hox* genes, the repressive histone mark H3K27me3 is removed, accompanied by an increase in the activation mark H3K4me3 ([@B3]). The activated *Hox* genes loop out from the repressive chromatin compartment and constitute an activated chromatin center ([@B4]). Determination of cell fate during differentiation is spatially and temporally regulated by *Hox* gene activation. The maintenance of bivalent chromatin in ESCs is therefore essential for the appropriate activation of the *Hox* genes and early embryonic development.

Polycomb Repressive Complex 2 (PRC2) occupies large domains of *Hox* genes ([@B5],[@B6]) and maintains the repressive histone mark H3K27me3. The mechanism by which PRC2 is recruited to specific chromatin loci in vertebrates is poorly understood. Recent studies demonstrate that long noncoding RNAs (lncRNA) play important roles in the recruitment of PRC2 ([@B7]). LncRNA *RepA* within the *Xist* locus directly interacts with PRC2 and recruits it to X-chromosome for the initiation of X-chromosome inactivation ([@B8]). Another lncRNA *Kcnq1ot1* has been shown to interact with PRC2 and is involved in *Kcnq1* gene silencing ([@B9]). For *Hox* gene regulation, it has been reported that lncRNA *HOTAIR* is essential for PRC2 recruitment to the *HOXD* cluster at different developmental stages and in a variety of tissues ([@B10]--[@B13]). However, until now, lncRNAs have not been identified in the recruitment of PRC2 for *Hox* genes repression in ESCs. While lncRNAs regulate gene expression through diverse mechanisms, the most prevalent function of the lncRNAs is to target genes that are adjacent to their transcription site ([@B14]). Abundant lncRNAs are transcribed around the *Hox* gene cluster ([@B3],[@B10]). In mESCs, RIP-sequencing identified thousands of lncRNAs that interact with PRC2 ([@B15]). Among these lncRNAs, several are located near the *Hox* gene cluster and one lncRNA, *Gm15055* (also known as *Haunt, Halr1* and *linc-HOXA1*, referred to as *Gm15055* hereafter), is approximately 50 kb downstream of the *Hoxa1* gene. *Gm15055* was first predicted by the 'K4-K36 domain' feature in mESCs ([@B16]) and then identified by RNA-sequencing in mESCs ([@B17]). Maamar et al. reported that there are three isoforms of *Gm15055* (isoform 1, 2, and 3) and that the transient knockdown of this lncRNA in mESCs specifically increases the expression of *Hoxa1* ([@B18]). The function of *Gm15055* has also been investigated in mice by replacing the second and third exons with *lacZ* and a selection marker; however, no obvious developmental defects were reported ([@B19]). Considering that the four *Hox* gene clusters may have redundant functions in vertebrate development, function of *Gm15055* in the regulation of *Hoxa* genes remains to be characterized.

In this study, we applied lentiviral-mediated stable knockdown of *Gm15055* and CRISPR/Cas9-mediated *Gm15055*-knockout in mESCs to investigate the regulation of *Hoxa* gene expression and chromatin status in mESCs by the lncRNA *Gm15055*. We found that *Gm15055* was positively regulated by OCT4 and highly expressed in mESCs. *Gm15055* interacted with PRC2 and recruited PRC2 to *Hoxa* gene cluster for maintaining the repressive histone mark H3K27me3 on the *Hoxa* gene promoters in mESCs. We further showed that long-distance chromatin interactions exist between the *Gm15055* locus and the *Hoxa* gene cluster, which may help in the targeting of *Gm15055*-recruited PRC2 to the *Hoxa* gene cluster. Finally, a DNA fragment located within the *Gm15055* gene locus was identified as an OCT4-dependent *cis-*regulatory element that potentially upregulates both *Gm15055* and *Hoxa* genes expression.

MATERIALS AND METHODS {#SEC2}
=====================

Cell culture {#SEC2-1}
------------

The mouse embryonic cell line JM8A3 was grown and maintained according to the supplier\'s instructions. Briefly, the cells were cultured at 37°C in a 5% (v/v) CO~2~ incubator in Knock-Out DMEM medium (Invitrogen) supplemented with 15% KSR (Invitrogen), 2 mM L-glutmax (Invitrogen), 1× nonessential amino acids (Invitrogen), 10^3^ U/ml LIF (Millipore), and 55 μM 2-mercaptoethanol. The dishes were coated with 0.1% gelatin \[v/v\], and a layer of MMC-treated DR4 cells (for selection) or MEF cells was grown on top as feeder cells. The cells were passaged as needed, and the growth medium was changed daily. Upon harvesting the JM8A3 cells, the feeder cells were removed by incubation at 37°C on gelatin-coated dishes for 1.5 h. For embryoid body (EB) differentiation, the JM8A3 cells were suspended in DMEM basic medium (Invitrogen) supplemented with 10% FBS (Invitrogen) and cultured on ultra-low attachment cell culture plate (Corning). For all-trans retinoid acid (ATRA) induced differentiation, JM8A3 cells were maintained in ESC culture medium without feeder cells, and induced by withdraw of LIF and the addition of 5 μM ATRA (Sigma).

Gene knockdown and overexpression {#SEC2-2}
---------------------------------

For stable knockdown of *Gm15055* in mESCs, shRNA hairpins were cloned into the plko.1 lentiviral vector, which contains a puromycin marker gene that allows for stable integration as previously described ([@B20]). Briefly, two hairpins were designed to target *Gm15055*, and one hairpin targeting GFP was used as the control. The target sequences of the three shRNAs were as follows: shGFP: TGACCCTGAAGTTCATCTGCA; shGm15055-1: ATATGAGTGAAGTCACAA ATG; shGm15055-2: GCCTAGTTCAACGACACATCA.

Lentiviruses containing the shRNAs were then prepared as previously described ([@B20]). For each shRNA plasmid, 1 μg of the shRNA vector and 0.5 μg of pMD2.G, 0.5 μg of pMDLg/pRRE, and 0.5 μg of pRSV-Rev were co-transfect into 2 × 10^6^ 293T packaging cells using 5 μl Lipofectamine2000 (Invitrogen). The viral supernatant was harvested at 48 and 72 h after transfection and purified with a 0.45-μm filter (Millipore). Then, 3 × 10^5^ JM8A3 mESCs depleted of MEF cells were infected with the viruses at 37°C for 30 min before being cultured on DR4 feeder cells for 48 h. For selection, 1.5 ng/μl puromycin was added to the cultures, and the medium was changed daily. The transfected cells were harvested after 8 days of selection.

For *Oct4* knockdown, two siRNAs (Invitrogen) targeting *Oct4* and one control siRNA (Invitrogen, 4404021) were synthesized. Then, 5 × 10^5^ JM8A3 cells were transfected with 125 or 100 pM of each siRNA with 5 μl Lipofectamine2000 and cultured on MEF feeder cells for 2 days before harvesting. The siRNA sequences are as follows: SiOct4-1: CGGAAGAGAAAGCGAACTA; SiOct4-2: CGGAAGAGAAAGCGAACTA.

For *Gm15055* overexpression, the three isoforms of *Gm15055* were cloned into the pcDNA3.1 vector, and the empty pcDNA3.1 was used as a control. Two micrograms of each plasmid was electrotransfected into 5 × 10^5^ JM8A3 cells using the Neon transfection system (Invitrogen) with the parameters of 1350 V, 10 ms and three pulses. The cells were harvested 48 h after transfection.

For *Oct4, Sox2 and Nanog* overexpression in MEF, the same amount of pMXs-*GFP/Oct4/ Sox2/Nanog* viral supernatant was incubated with MEF and the cells were harvested 36 h after infection.

Gene targeting, selection and removal of selection markers {#SEC2-3}
----------------------------------------------------------

The CRISPR/Cas9 system for *Gm15055* gene targeting was performed as previously described ([@B21]). Briefly, two guide RNAs (gRNA3: TAGAGGAACAATTGCTGCAT and gRNA5: CTTTGAAAAGAAGTGAAGGA) were cloned into the PX330 vector and used in combination with two targeting vectors (DTA and PB) with different selective markers, allowing for two rounds of knockout experiments to achieve homogenous *Gm15055* ablation. The targeting vectors replaced a 1894-bp DNA fragment (mm9 chr6:52 055 891--52 057 784) of the *Gm15055* locus with a transcription termination signal and a neomycin or puromycin resistance gene. Then, 5 μg of the guide RNA plasmid, 5 μg of the CAG-Cas9 vector and 5 μg of the targeting vector were co-transfected into 5 × 10^6^ JM8A3 cells using the Neon transfection system (Invitrogen) and selected with 1.5 ng/μl puromycin or 150 ng/μl G418 for 8 days with daily media changes. Single JM8A3 clones were identified by PCR and RT-qPCR to verify the successful knockout of *Gm15055*. The selection markers were then removed from the homozygous *Gm15055* knockout clones by electrotransfection of the PBase and pCAG-cre vectors and negative selection with 200 nM 1-(2-deoxy-2-fluoro-beta-[d]{.smallcaps}-arabinofuranosyl)-5-iodouracil (FIAU) for 10 days. The resulting clones were then selected and identified by PCR before subsequent analysis. The primers used for PCR identification of the knockout clones, as well as for the detection of potential off-target effects, are listed in Supplementary Table S1.

BoxB tethering assay {#SEC2-4}
--------------------

A BoxB tethering assay was performed as previously described with some modifications ([@B22]). A DNA fragment containing five tandem GAL4 UAS sites was inserted into the DTA targeting vector mentioned above and stably integrated into the *Gm15055* gene locus of JM8A3 to prepare the UAS-JM8A3 cells after G418 selection. The vector encoding GAL4-λN hybrid protein was subsequently tranfected into the cells and selected with puromycin to obtain the UAS-GAL4-λN-JM8A3 clones. Finally, the vector harboring the isoform 3 *Gm15055* fused with 5BoxB sequence was transfected into the UAS-GAL4-λN-JM8A3 cells and selected with 160 ng/μl hygromycin. The LacZ-5BoxB plasmid (addgene 29729) was used as a negative control. All the resultant JM8A3 clones were identified by PCR and RT-qPCR to verify the UAS insertion, GAL4-λN expression and 5BoxB-fused RNA expression. The positive clones were then harvested for RT-qPCR and ChIP-qPCR analyses to detect the transcription and PRC2 recruitment at the Neo gene downstream to the UAS site.

Chromatin immunoprecipitation (ChIP) {#SEC2-5}
------------------------------------

A ChIP assay was performed as previously described with some modifications ([@B23]). Briefly, mESCs were crosslinked with 1% formaldehyde for 15 min and lysed with lysis buffer (1% SDS, 10 mM EDTA and 50 mM Tris--HCl, pH 8.0) supplemented with protease inhibitors. The lysed cells were sheared until the chromatin DNA fragments were 200--1000 bp in size. The sonicated chromatin was then diluted 10-fold with ChIP dilution buffer (0.01% SDS, 1% Triton X-100, 150 mM NaCl, 2 mM EDTA and 20 mM Tris--HCl, pH 8.0) and pre-cleared using protein A/G Dynabeads (Invitrogen) before incubation with anti-Oct4 (ab19857, abcam), anti-H3K27me3 (07-449, Millipore), anti-H3K4me3 (07-473, Millipore), anti-H3 (ab1791, abcam), anti-Suz12 (17-661, Millipore or ab12073, abcam) and anti-RNA polymerase II CTD repeat YSPTSPS (phospho S5) (ab5131, abcam) antibodies or normal rabbit/mouse IgG (Santa Cruz) at 4°C overnight. The antibody-chromatin complexes were recovered by incubation with protein A/G Dynabeads (Invitrogen) at 4°C for 2 h. After washing and reverse cross-linking, the precipitated DNA was purified and subsequently analyzed by real-time PCR. The PCR products of the ChIP samples were normalized to the input DNA or H3 density. The IgG-precipitated DNA was used as a negative control for each ChIP assay. The ChIP was then repeated in triplicate with the *Gm15055*-knockdown cells and was repeated with at least three *Gm15055* knockout clones. All the primers used for the ChIP-qPCR assay are listed in Supplementary Table S3.

Chromosome conformation capture {#SEC2-6}
-------------------------------

Chromatin conformation capture (3C) was performed as previously described ([@B23],[@B24]). Briefly, the crosslinked mESCs (1% formaldehyde, 15 min) or MEFs (1% formaldehyde, 10 min) were digested with HindIII (NEB, R0104M) overnight, and the digestion efficiency was calculated by real-time PCR amplification of uncut fragments with primer pairs spanning the designated HindIII sites. A digestion efficiency of \>80% at each individual restriction site is considered feasible for further 3C analysis. The samples were then ligated with 2 U/μl T4 DNA ligase (NEB, M0202M) at 16°C for 4 h at DNA concentrations of less than 2.5 ng/μl. After reversing the cross-links, the 3C sample was purified by phenol extraction and ethanol precipitation and then washed with 70% cold ethanol six times before qPCR quantification. The mouse *Hoxa* BAC clone (RP23--20F21) for control library construction was obtained from the Children\'s Hospital Oakland Research Institute and was used to correct the primer efficiency. Seven primer pairs amplifying control regions were used to correct for the template amount. The relative interaction frequencies between the two designated DNA fragments were then calculated by normalizing the PCR efficiency of the 3C samples to their respective controls. All of the qPCR was repeated in triplicate using at least three independent cultures. The primers used for the 3C-qPCR analyses are listed in Supplementary Table S4.

RNA immunoprecipitation (RIP) {#SEC2-7}
-----------------------------

RIP was performed as previously described ([@B10],[@B18]). JM8A3 cell lysates were prepared by suspending 5 × 10^7^ cells in 4 ml RIP buffer (150 mM KCl, 25 mM Tris at pH 7.4, 5 mM EDTA, 0.5 mM DTT, 0.5% NP40, 1× protease inhibitor cocktail \[Sigma\]) followed by incubation at 4°C for 30 min with gentle rotation. The cell lysates were then sonicated and cleared by centrifugation at 13 000 rpm for 20 min. The protein concentration of the lysate was quantified with the BCA protein assay kit (Pierce). Antibodies recognizing Suz12 (17-661, Millipore) or IgG (Santa Cruz) were incubated with 0.4 mg cell lysate at 4°C for 2 h with gentle rotation. Then, 30 μl of protein G/A Dynabeads (Invitrogen) was added and incubated for another 1 h. The beads were collected and washed three times with RIP buffer containing SUPERaseIn (Ambion). The RNA was extracted with 1 ml Trizol (Invitrogen) according to the manufacturer\'s instructions before quantification by RT-qPCR.

Reporter assay {#SEC2-8}
--------------

The enhancer activity of the knockout DNA fragment was analyzed using the dual-luciferase reporter assay (Promega). Briefly, the DNA fragments were inserted into the pGL3-promoter vector or pGL3 basic vector and transfected into 293T, JM8A3 or MEF cells with a Renilla luciferase-encoding vector (pRL-CMV) as the internal control. The pMXs-control/*Oct4* vectors were co-transfected with the reporters to test the regulatory effects of these factors to the target DNA fragments. The luciferase activity (firefly/Renilla) was measured using a Modulus Microplate Multimode Reader. For OCT4 binding sites mutation, the wildtype reporters were amplified by primers containing the mutated nucleotides, followed by Dpn I digestion to remove the wildtype templates. All mutated reporters were confirmed by sequencing. For each reporter assay, three biological replicates were examined and each sample was analyzed by three technical replicates. The primer pairs used for reporter vector construction are listed in Supplementary Table S5.

Statistical analysis {#SEC2-9}
--------------------

Data analysis was performed with GraphPad Prism6 (GraphPad Software, Inc.). The data are presented as the mean ± SD. The differences among samples were compared using Student\'s *t*-test and the *P*-values were indicated: \*\**P* \< 0.01, \**P* \< 0.05.

RESULTS {#SEC3}
=======

OCT4 regulates the elevated expression of lncRNA *Gm15055* in mESCs {#SEC3-1}
-------------------------------------------------------------------

*Gm15055* was first predicted and identified in mESC ([@B16],[@B17]). To determine whether *Gm15055* is expressed specifically in mESCs, we investigated its expression in mouse embryonic tissues at different developmental stages and during mESC differentiation. Tailbuds were collected from mouse embryos at 8.5 days and 9.5 days, and yolk sac cells and MEF cells were collected from mouse embryos at 14.5 days. The *Gm15055* expression level was then detected by RT-qPCR and compared to its expression in mESCs. As expected, we observed that *Gm15055* expression was higher in mESCs and obviously lower in the differentiated cells (Figure [1A](#F1){ref-type="fig"}). Similarly, we showed that the expression of *Gm15055* is largely decreased during the first few days of embryoid body (EB) differentiation of mESCs (Figure [1B](#F1){ref-type="fig"}).

![LncRNA *Gm15055* is maintained by OCT4 in mESCs. (**A**) *Gm15055* expression in mESCs, E8.5 and E9.5 mouse tailbuds, E14.5 mouse yolk sac and MEF cells was quantified by RT-qPCR. The expression levels are shown relative to that of mESCs; *Gapdh* was used as an internal control. (**B**) The relative expression of *Gm15055* and *Oct4* during embryoid body differentiation of mESCs was detected by RT-qPCR at the indicated time points. (**C**) RT-qPCR detection of the *Oct4* knockdown efficiency and the resulting *Gm15055* expression in mESC. Two siRNAs targeting m*Oct4* (SiOct4-1 and SiOct4-2) and one control siRNA (SiNC) were used, with two different amounts of siRNA as indicated. (**D**) The pluripotency factors *Oct4, Sox2, Nanog* were overexpressed separately or in combination in MEF cells and the expression level of the endogenous *Gm15055* was detected by RT-qPCR. GFP overexpression was used as a control. +OS: *+Oct4+Sox2*; +OSN: *+Oct4+Sox2+Nanog*. (**E**) Recruitment of OCT4 at the *Gm15055* locus was analyzed by ChIP-qPCR. Three potential OCT4 binding regions at the *Gm15055* locus (namely OBR 1, OBR 2 and OBR 3) and the *Gm15055* promoter (GmP) were examined. (**F**) The activity of OCT4 on *Gm15055* promoter with or without the downstream OCT4 binding regions were detected in reporter assay in 293T cells. The pGL3 basic (Basic), *Gm15055* promoter-pGL3 (GmP) or OCT4 binding region 2/3-*Gm15055* promoter-pGL3 (OBR 2/3-GmP) reporters, was co-transfected with empty or *Oct4* overexpression vector, respectively. The relative luciferase activity was normalized to that of the Basic plus empty overexpression (OE empty) group. (**G**) Reporter assay in 293T cells showed that mutation to the OCT4 binding sites abolished the response of *Gm15055* promoter to the OCT4 activity. The pGL3 basic (Basic), *Gm15055* promoter-pGL3 (GmP) or that carrying single/double mutations at the *Gm15055* promoter (GmP mut1, GmP mut2 and GmP mut1+2), was co-transfected with empty or *Oct4* overexpression vector, respectively. The relative luciferase activity was normalized to that of the Basic plus empty overexpression (OE empty) group.](gkv1315fig1){#F1}

The expression pattern of *Gm15055* was found highly correlated to that of *Oct4* during EB differentiation, except at day 1 (Figure [1B](#F1){ref-type="fig"}). Given that the *Oct4* gene is an important pluripotency marker of mESCs and that the previous ChIP-seq assay with OCT4 in mESCs showed a strong signal at the *Gm15055* locus ([@B25],[@B26]), it is possible that OCT4 participates in the maintenance of the high level of *Gm15055* expression in mESCs. Knockdown *Oct4* gene expression by two different siRNAs led to a decrease in *Gm15055* expression (Figure [1C](#F1){ref-type="fig"}). Considering that decrease of *Oct4* expression could lead to ESC differentiation, we repeated the *Oct4* knockdown assay using a relatively lower amount of siRNA at 100pmol to avoid the potential ESC differentiation ([@B27]). RT-qPCR results showed that *Gm15055* expression remained decreased upon the mild *Oct4* knockdown (Figure [1C](#F1){ref-type="fig"}), meanwhile both immunofluorescence assays of the pluripotent factors OCT4, SOX2, NANOG, SSEA1 and the AP staining (Supplementary Figure S1) showed no traits of ESC differentiation with the mild knockdown of *Oct4*. Moreover, although overexpression of *Oct4* alone showed no obvious effect on *Gm15055* expression, the co-transfection with its co-factor *Sox2* significantly promoted endogenous *Gm15055* expression in the MEF cells (Figure [1D](#F1){ref-type="fig"} and Supplementary Figure S2A). Specifically, Recent OCT4 ChIP-seq data from Whyte *et al*. and Buecker *et al*. ([@B25],[@B26]) showed two OCT4 binding regions (OBR) at *Gm15055* locus, a minor one at the promoter of *Gm15055* (GmP) and a major one around the Exon 2, which includes three peaks of OCT4 binding signals (OBR-1,-2,-3) (Supplementary Figure S2B). The binding of OCT4 at those sites in JM8A3 were then confirmed using conventional chromatin immunoprecipitation assay (Figure [1E](#F1){ref-type="fig"}). Further reporter assay in 293T cells showed that OCT4 stimulated transcription from *Gm15055* promoter, and that the stimulation became a bit more obvious when a fragment of the OBR (containing OBR-2 and -3) was inserted into the reporter (Figure [1F](#F1){ref-type="fig"}). Two core OCT4 binding sites were then predicted from the *Gm15055* promoter by FIMO ([@B28]), mutations to either of them abrogated the stimulative effect of OCT4 to the promoter (Figure [1G](#F1){ref-type="fig"}). Taken together, these results indicate that OCT4 maintains *Gm15055* expression in mESCs.

*Gm15055* represses *Hoxa* gene expression *in* mESC {#SEC3-2}
----------------------------------------------------

Previous study by Maamar *et al*. found that *Gm15055* functions as a repressor of the *Hoxa1* gene ([@B18]). Using two separate lentiviruses carrying different *Gm15055*-targeting shRNA sequences, we stably knockdown *Gm15055* expression in mESCs and observed a de-repression of all the *Hoxa* genes, except for *Hoxa13*, in the uninduced mESCs (Supplementary Figure S3A-B). The level of de-repression was comparable to that of *Hoxa* activation during the first few days of embryoid body differentiation (Supplementary Figure S3C). Alkaline phosphatase staining, as well as immunofluorescence and RT-qPCR analysis of the pluripotency markers SSEA1 and *Oct4*, confirmed that the pluripotency of the mESCs was not disrupted by *Gm15055* knockdown, and excluded the possibility that the increased *Hoxa* gene expression is due to mESC differentiation (Supplementary Figure S4A--C). Overexpression of *Gm15055* isoforms failed to cause obvious change in *Hoxa* expression (Supplementary Figure S5A-B), The observations were consistent to a recent paper published during the revision of this work, reporting that *Gm15055* regulates the activation of *Hoxa* genes upon RA-induced ESC differentiation, and that *Gm15055* acts on *Hoxa* gene in *cis* ([@B29]).

*Gm15055* maintains the H3K27me3 modification of *Hoxa* genes by recruiting PRC2 {#SEC3-3}
--------------------------------------------------------------------------------

Bivalent chromatin is a prominent feature of the *Hox* genes in mESCs. We then examined whether *Gm15055* represses the *Hoxa* genes by affecting chromatin modification. A ChIP assay showed that *Gm15055* knockdown was accompanied by the decline of the H3K27me3 modification on all of the *Hoxa* gene promoters, the *Gata-6* promoter was used as negative control to show that the effect was specific to the *Hoxa* locus (Figure [2A](#F2){ref-type="fig"}). H3K4me3 modification at the *Hoxa* gene promoters was largely unaffected (Supplementary Figure S6A). A similar but more 3′-proned elimination of H3K27me3 modification from the *Hoxa* locus was detected in RA-induced *Gm15055* pKO ESC in the recent report ([@B29]).

![*Gm15055* interacts with PRC2 and maintains the repressive H3K27me3 modification and PRC2 binding to the *Hoxa* gene promoters. (**A**) ChIP analysis of H3K27me3 modification at the Hoxa gene promoters in the control shGFP and the Gm15055-knockdown (shGm15055-1 and shGm15055-2) mESCs. All H3K27me3 signals were normalized to the H3 density at the same site, and the *Gata6* promoter (Gata6P) was used as a control region. (**B**) ChIP analysis showing the recruitment of the PRC2 core component SUZ12 at the *Hoxa* gene promoters in the control shGFP and the Gm15055-knockdown mESCs. The *Gata6* promoter (Gata6P) was used as a control region. (**C**) RNA immunoprecipitation (RIP) showed that PRC2 specifically interacted with *Gm15055*. An antibody against the PRC2 core component SUZ12 was used to pull down PRC2, and normal IgG was used as a negative control. *Gm15055* and two other control RNAs (*U2* and *Gapdh*) were then detected in both the anti-SUZ12 and IgG RIP samples. (**D**) Working model of the BoxB tethering assay. The GAL4-λN chimeric protein recognizes the BoxB-tethered RNA and targets the RNA to the 5×UAS locus that was integrated into the mESC genome. The *cis*-regulatory effect of the tethered Gm15055 isoform 3 RNA can then be evaluated by detecting the expression level and histone modification of the adjacent *Neo* gene. E. RT-qPCR analysis of the *Neo* gene adjacent to the UAS locus showing the repressive effect brought by the tethered *Gm15055* (isoform 3) RNA. All the three constructs, the UAS-neo, GAL4-λN, BoxB-Gm15055 or BoxB-LacZ were stably integrated in the JM8A3 mESCs. (F--G) ChIP analysis showed the increased (**F**) recruitment of the PRC2 core component SUZ12 and (**G**) H3K27me3 modification at the *Neo* locus at the *Gm15055* (isoform 3) group in the BoxB tethering assay. UG: JM8A3+UAS+GAL4λN, UGL: JM8A3+UAS+GAL4λN+BoxBLacZ, UGG: JM8A3+UAS+GAL4λN+BoxB*Gm15055*. UG and UGL ESCs were used as the negative controls, and the *Gata6* promoter (Gata6P) was used as an irrelevant control region in the ChIP assay.](gkv1315fig2){#F2}

PRC2 is the main protein complex responsible for H3K27me3 modification. We therefore investigated whether the recruitment of PRC2 to the *Hoxa* locus was affected by *Gm15055* knockdown. A ChIP assay showed that the signal of SUZ12, a core component of PRC2, decreased at the *Hoxa* gene promoters, but not at the control *Gata-6* promoter, in both *Gm15055*-knockdown mESCs (Figure [2B](#F2){ref-type="fig"}). The protein level of SUZ12 in the cells was shown unchanged (Supplementary Figure S6B). These results suggest that *Gm15055* may repress the expression of the *Hoxa* genes by affecting PRC2 binding at the promoters of the *Hoxa* genes.

To clarify how *Gm15055* may affect PRC2 recruitment to the *Hoxa* gene promoters, we first detected and confirmed the nuclear distribution of *Gm15055* RNA (Supplementary Figure S6C). The nuclear RNA *U2*, and cytoplasm-enriched *Gapdh* and *Oct4* mRNAs were using as the controls for the analysis. RNA immunoprecipitation (RIP) assay against SUZ12 was then performed to determine the ability of *Gm15055* RNA in recruiting PRC2 complex. The results revealed that SUZ12 interacted specifically with *Gm15055 in vivo*. Interactions between SUZ12 and the two control RNAs *U2* and *Gapdh* were not detected (Figure [2C](#F2){ref-type="fig"}). Next, a stable BoxB tethering assay was carried out to examine whether *Gm15055* is able to target PRC2 to the neighboring genes ([@B22]). The longest isoform of *Gm15055*, isoform 3, was fused with the BoxB RNA and, through a mediating GAL4-λN chimeric protein, could be tethered to the UAS sequence upstream to a *neo* selection marker gene (Figure [2D](#F2){ref-type="fig"}, Supplementary Figure S7A). All the UAS-neo, GAL4-λN, and *Gm15055*-BoxB expressing vectors were stably integrated into the genome of mESCs. Blank, BoxB-lacZ RNA expressing vectors were used as the negative controls. The mESC clones that showed comparable expression of GAL4-λN and BoxB-tethered RNA were selected for further examination (Supplementary Figure S7B-C). RT-qPCR results showed that BoxB-*Gm15055* overexpression led to obviously decreased *neo* gene expression, compared to that in the blank and BoxB-lacZ-overexpressing mESCs (Figure [2E](#F2){ref-type="fig"}). Moreover, the tethering of *Gm15055* led to a significant increase of SUZ12 binding and H3K27me3 modification at the *neo* gene adjacent to the UAS sequence (Figure [2F](#F2){ref-type="fig"}-[G](#F2){ref-type="fig"}), confirming the ability of *Gm15055* to recruit PRC2 to a specific gene locus.

Long-range chromatin interaction may facilitate loading of PRC2 to the *Hoxa* locus {#SEC3-4}
-----------------------------------------------------------------------------------

The *Gm15055* gene locus is approximately 50 kb downstream of the *Hoxa* gene cluster. To understand how *Gm15055* RNA may recruit PRC2 to the *Hoxa* gene cluster across such a long distance, we applied chromosome conformation capture (3C) to examine whether the *Gm15055* locus interacts with the *Hoxa* gene cluster in wild type mESCs. The recent study showed a relatively weak chromatin interaction in between the two loci in uninduced ESCs, using the *Hoxa1* and *a5* promoters as the leader fragments (anchors) ([@B29]). Reversely, we used here the three HindIII restriction fragments from the *Gm15055* locus as the 3C leaders: a '+54K' fragment containing the *Gm15055* promoter, a '+51K' fragment containing exon 2 of *Gm15055* and a CTCF binding site (CBS) ([@B30]), and a '+47K' fragment, which covered the majority of the second intron of *Gm15055* (Figure [3A](#F3){ref-type="fig"}). Restriction fragments covering the vicinity downstream of the *Hoxa* cluster and those containing the *Hoxa* promoters---the +10k, +4k, A1P, A2P, A3, A4P, A5P, A6P, A7P, A9P, A10aP, A10bP, A11P and A13P fragments---were analyzed by the 3C assay. The fragments are named according to their position relative to the *Hoxa* gene cluster or the *Hoxa* promoter. The 3C results showed that the +54K fragment was preferentially associated with the *Hoxa9* promoter, and the +47K fragment selectively engaged with the *Hoxa7* promoter. The +51K fragment, which contains the CBS, was extensively associated with most of the *Hoxa* promoter regions that have been detected (Figure [3B](#F3){ref-type="fig"}-[D](#F3){ref-type="fig"}). Interestingly, the +4K fragment that was immediately downstream of the *Hoxa* cluster exhibited a high frequency of interaction with both the +54K and +47K leaders, bioinformatic analysis revealed enriched binding of the pluripotent factors OCT4, SOX2 and NANOG at the region (Supplementary Figure S8), implying a potential role of the fragment in mediating the interaction between *Gm15055* locus and the *Hoxa* gene cluster.

![Long-range chromatin interactions exist between the *Gm15055* gene locus and the *Hoxa* gene cluster. (**A**) A schematic representation of the *Gm15055* and the *Hoxa* genes loci with the analyzed DNA fragments in the 3C experiment highlighted. The +54K, +51K and +47K leader fragments from the *Gm15055* locus are marked as red, purple and pink, respectively. The other 3C fragments are marked as orange. Fragments outside of the Hoxa gene cluster are named according to their distance to the 3′-end of the cluster. Other fragments refer to the respective Hoxa gene promoters (e.g. A1P refers to promoter of *Hoxa1*). (B--D) Chromosome conformation capture assay of the interaction frequencies between the leaders (**B:** +54K; **C:**+51K; **D:** +47K) and the *Hoxa* gene cluster in control (shGFP) and two *Gm15055* knockdown (shGm15055-1 and shGm15055-2) JM8A3 mESCs. All interaction frequencies were normalized to the highest interaction frequency detected for each respective leader fragment. The P-values are indicated in the form of shGm15055--1 vs shGFP/shGm15055--2 vs shGFP. (E--G) Chromosome conformation capture assay of the interaction frequencies between the leaders (**E:** +54K; **F:**+51K; **G:** +47K) and the *Hoxa* gene cluster in JM8A3 mESCs and the JM8A3 that was induced by all-trans retinoid acid for two days (+RA D2). All interaction frequencies were normalized to the highest interaction frequency detected for each respective leader fragment.](gkv1315fig3){#F3}

Upon knockdown of *Gm15055*, interactions of the +51K leader and the *Hoxa* cluster are specifically affected, with an increase observed at the 3′-part of the *Hoxa* cluster (+10K to A5P), and a decrease at the 5′ of the cluster, especially at the A7P fragment (Figure [3C](#F3){ref-type="fig"}). We further showed that the interactions between the two loci were strengthened after RA-induced mESC differentiation, with the only exception observed for the +4K fragment, where the 3C signal decreased (Figure [3E](#F3){ref-type="fig"}--[G](#F3){ref-type="fig"}). The changes became even obvious in the more differentiated MEF cells (Supplementary Figure S9). Close physical associations have previous been shown to mediate the Xist-initiated X-chromosome inactivation ([@B31]). The physical interactions of *Gm15055* and the *Hoxa* loci hence may supply a similar platform for the *Gm15055*-recruited PRC2 to target and spread on *Hoxa* gene cluster, and the *Gm15055* RNA itself might participate in regulating this chromatin conformation to a more 5′-proned structure in mESC.

*Gm15055* knockout decreases H3K27me3 modification and PRC2 binding on *Hoxa* genes {#SEC3-5}
-----------------------------------------------------------------------------------

We went on to confirm the role of *Gm15055* in PRC2 recruitment using CRISPR/Cas9- mediated knockout in JM8A3 mESCs. Two effective guide RNAs (gRNAs), gRNA3 or gRNA5, were used in combination with a gene targeting vector to homozygously delete a ∼1.9-kb DNA fragment of *Gm15055* (mm9 chr6:52 055 891--52 057 784). The deleted region covers exon 2 of *Gm15055* as well as the surrounding OCT4 and CTCF binding sites ([@B26],[@B30]), and was replaced with a polyA transcription termination signal (Figure [4A](#F4){ref-type="fig"}). Homozygous *Gm15055* knockout and the successful removal of the selective markers were validated by DNA sequencing. The sites that were predicted to have the highest off-target potential ([@B32]) were examined in both single-gRNA- and double-gRNA-targeted mESC clones and were confirmed to have no nucleotide mutations compared to the wild type sequence (Supplementary Figure S10). RT-PCR analysis of exons 2 and 3 in the homozygous *Gm15055* knockout mESC clones confirmed the successful ablation of *Gm15055* expression (Figure [4B](#F4){ref-type="fig"}). A pluripotency assay of the *Gm15055* knockout clones with AP staining (Supplementary Figure S11A) and immunofluorescence analysis of SOX2, NANOG, OCT4, SSEA1 (Supplementary Figure S11B) was then carried out and indicated no significant changes in the *Gm15055* knockout clones.

![Knockout of *Gm15055* in mESCs decreases H3K27me3 modification and PRC2 binding on *Hoxa* gene promoters. (**A**) A schematic representation of the strategy and site of *Gm15055* knockout. The highlighted blue region represents the knocked-out fragment of the *Gm15055* locus. The DTA and PB targeting vector with a transcription termination poly(A) signal and a selection marker flanked by two homologous arms are shown at the bottom. Two CRISPR guide RNAs, the gRNA3 and gRNA5, were used in combination with the targeting vector to knockout each allele. The OCT4 ChIP-seq data are from Buecker, et al. 2014. Cell Stem Cell ([@B26]) and the CTCF ChIP-seq data are from ENCODE ([@B30]). (**B**) RT-qPCR confirmed the successful elimination of *Gm15055* expression in *Gm15055*-knockout mESC clones. Two pairs of primers were used for the amplification of exon 2 and exon 3. All expression levels are shown relative to that of wild type JM8A3 cells. (C and D) Representative ChIP results of (**C**) H3K27me3 modification, (**D**) SUZ12 binding on *Hoxa* gene promoters before and after *Gm15055* knockout in mESCs. All histone modification signals are normalized to H3 density and the *Gata6* promoter (Gata6P) is used as a control region.](gkv1315fig4){#F4}

H3K27me3, H3K4me3 modifications and the binding of the PRC2 core component SUZ12 to the *Hoxa* gene locus were then examined in the *Gm15055* knockout clones. Decreased H3K27me3 modification and SUZ12 binding were detected at the *Hoxa* gene promoters, the *Gata-6* promoter was used as negative control (Figure [4C](#F4){ref-type="fig"} and [D](#F4){ref-type="fig"}). The expression of *Suz12* also remained unchanged, indicating that the defect involves the recruitment of SUZ12 (Supplementary Figure S12A). No significant changes in H3K4me3 modification were observed at the *Hoxa* gene promoters in the *Gm15055* knockout clones, similar to the observations in the knockdown clones (Supplementary Figure S12B).

An OCT4-responsive *cis*-element within the *Gm15055* locus potentially upregulates the transcription of both *Gm15055* and the *Hoxa* genes {#SEC3-6}
--------------------------------------------------------------------------------------------------------------------------------------------

RT-qPCR examination of the *Gm15055*-knockout clones, however, revealed decreased expression of most *Hoxa* genes (Figure [5A](#F5){ref-type="fig"}). Moreover, embryoid body (EB) differentiation of the KO cells showed compromised activation of the *Hoxa* genes at day 8, when rapid *Hoxa* activation is started in wild-type mESC (Figure [5B](#F5){ref-type="fig"} and Supplementary Figure S13). Slight decrease in the activation of some *Hoxa* genes were also detected in *all-trans* retinoid acid (ATRA) induced differentiation of the KO cells, a model that is much faster than the EB differentiation model (Supplementary Figure S14). Our observation, together with the recent report about several other types of *Gm15055*-KO, support the existing of positive *cis-*regulatory element within the locus ([@B29]). Interestingly, severe decrease in the transcription of *Gm15055* exon 1 and intron 1 was also observed in our *Gm15055*-knockout mESCs, although those regions were intact and protected by the polyA signal (Figure [5C](#F5){ref-type="fig"}). The decreases were accompanied with crippled Pol II binding and H3K4me3 modification at the *Gm15055* promoter, the *Gapdh* promoter was used as a negative control (Figure [5D](#F5){ref-type="fig"} and [E](#F5){ref-type="fig"}). These observations imply that the *cis-*element may regulate both the *Gm15055* and the *Hoxa* genes expression.

![Knockout *Gm15055* down-regulates most *Hoxa* genes and decreases transcriptional activity of *Gm15055* promoter. (**A**) RT-qPCR detection of *Hoxa* genes expression in *Gm15055*-knockout and the wild type mESC clones. For each *Hoxa* gene, the expression level is shown relative to that of the corresponding *Hoxa* gene in wild-type JM8A3 cells. (**B**) RT-qPCR detection of *Hoxa1-a3* expression in wild type and the *Gm15055-*knockout mESC during embryoid body differentiation. The time points (D0, D1, D2, D4, D6, D8, D10) indicated days after differentiation. See Supplementary Figure S13 for the analysis of the rest *Hoxa* genes. (**C**) RT-qPCR detection of *Gm15055* exon 1 and intron 1 expression in the *Gm15055-*knockout ESC. The wild type ESC was used as a control. (D and E) ChIP-qPCR analysis of (**D**) RNA polymerase II phospho S5 (POLIIS5) binding and (**E**) H3K4me3 modification on *Gm15055* promoter in the *Gm15055-*knockout and the wildtype ESCs. POLIIS5 binding and H3K4me3 modification at the *Gapdh* promoter in the two types of cells were shown as the control.](gkv1315fig5){#F5}

Reporter assays were then performed to confirm and dissect the knocked-out fragment for possible enhancer activity. The deleted region intersected the main OCT4 binding region of *Gm15055* in the OBR-2 and -3, and was hence demarcated into three successive parts, part A, B and C, with the first two parts contain OBR-2 and -3 respectively (Supplementary Figure S15C). Enhancer activities of each part were then investigated individually and in combination (A, B, C, AB, BC, ABC) in mESCs by inserting these fragments downstream a basal SV40 promoter. The deleted region, as an entity, exhibited significantly increased luciferase activity in the reporter assay. Among the three individual sub-fragments, only fragment A exhibited a weak enhancer activity, which was notably facilitated by fragment B (Figure [6A](#F6){ref-type="fig"}). This result suggests that fragment A, which contains the OBR-2 of strong OCT4 binding, processes the core enhancer sequence for gene activation, and fragment B with the weak OBR-3 plays an auxiliary role in the activity.

![A DNA fragment within the *Gm15055* gene locus possesses enhancer activity. (**A**) A reporter assay of the entire knockout fragment or the truncated fragment (named as ABC, AB, BC, A, B, C according to the contained sub-fragments) was performed in the JM8A3 ESC. The empty pGL3 promoter (pGL3P) vector was used as a control. The relative luciferase activity was normalized to that of the pGL3P. (**B**) Three OCT4 binding sites in the AB fragment were mutated separately (AB mut1, AB mut2, AB mut3) or in combination (AB mut1+2+3), and the reporter activities were detected in the JM8A3 ESC. The relative luciferase activity was normalized to that of the pGL3P. (**C**) *Hoxa* gene promoters with or without AB fragment were cloned into pGL3 basic vector and the reporter activities were detected in the JM8A3 ESC. The effect of AB fragment on the *Gm15055* promoter (GmP) was also investigated. The relative luciferase activity was normalized to that of the pGL3 basic vector (Basic). (**D**) Reporter assay of the AB fragment cloned in the pGL3P vector was carried out in the MEF cells. The relative luciferase activity was normalized to that of the pGL3P vector. (**E**) Enhancer activity of the AB fragment to all the *Hoxa* gene promoters and the *Gm15055* promoter (GmP) was detected in the MEFs. The relative luciferase activity was normalized to that of the pGL3 basic vector (Basic).](gkv1315fig6){#F6}

To further investigate how the enriched OCT4 binding contributes to the enhancer activity of the region, three OCT4 binding sites were predicted from the OBR-2 by JASPAR ([@B33]) and were mutated separately or together (Supplementary Figure S15C). The results showed that mutation to each OCT4 binding site significantly suppressed the enhancer activity of the AB fragment (mm9 chr6:52 055 891--52 057 264), and that simultaneous mutation to all the three sites impaired the enhancer activity to the most extent (Figure [6B](#F6){ref-type="fig"}), suggesting an important role of OCT4 binding to the enhancer activity of this region in mESCs.

We next examined the promoter-specificity ([@B34]) of the AB fragment. Each *Hoxa* gene promoter or the *Gm15055* promoter was inserted into the reporter construct with or without the AB fragment. Reporter assay in mESCs showed that the AB fragment increased the activity of *Gm15055* promoter and many *Hoxa* promoters, including the A2P, A4P, A5P, A6P, A7P and A11P (Figure [6C](#F6){ref-type="fig"}). Whereas in the mouse embryonic fibroblast (MEF) cells, where all *Hoxa* genes were activated (Supplementary Figure S16) and *Gm15055* was inactivated, the AB fragment no longer increases the activity of SV40 and *Gm15055* promoters (Figure [6D](#F6){ref-type="fig"}-[E](#F6){ref-type="fig"}) and showed a limited enhancive effect to a few *Hoxa* promoters including the A1P, A4P and A6P (Figure [6E](#F6){ref-type="fig"}).

DISCUSSION {#SEC4}
==========

In the present study, we found that the long noncoding RNA *Gm15055* is activated by the pluripotency factor OCT4 in mESCs and represses the adjacent *Hoxa* genes by recruiting PRC2 and maintaining the repressive histone mark H3K27me3 on the *Hoxa* gene cluster. *Gm15055* loops to the *Hoxa* locus, which may facilitate PRC2 binding on the *Hoxa* cluster. In addition to producing the repressive lncRNA, the *Gm15055* locus also contains an OCT4-dependent positive *cis*-regulatory element and may therefore contribute to both the high-level expression of *Gm15055* itself and the maintenance of a low but steady level of *Hoxa* gene expression in mESC.

OCT4 activates *Gm15055* expression in mESC {#SEC4-1}
-------------------------------------------

*Oct4*, together with *Sox2* and *Nanog* are core transcriptional factors for maintaining pluripotency of stem cells ([@B35]--[@B37]). High-throughput analysis of OCT4 binding sites in mouse ESC has revealed thousands of target sites through which OCT4 activates the ESC-enriched genes or suppresses the differentiation genes ([@B38]). In the present study, we showed that OCT4 positively regulates *Gm15055* expression without affecting cell differentiation, and demonstrated the direct targeting of OCT4 to the *Gm15055* locus by conventional ChIP as well as point mutations in the reporter assays. Other than acting on the promoter of *Gm15055*, OCT4 also activates a *cis*-regulatory element at around exon 2 of the locus and could hence contribute to enriched *Gm15055* expression in mESCs. Moreover, it was noticed that SOX2 and NANOG overlap with OCT4 in binding to the *Gm15055* locus (Supplementary Figure S15B)([@B25],[@B26]). Considering the repressive effect of *Gm15055* RNA to the downstream *Hoxa* genes, revealed by previous reports and the current data, and the essential roles of *Hox* genes in cell fate determination, we infer that mESC keeps abundant *Gm15055* expression by OCT4 and other pluripotency factors, to help in maintaining a robust pluripotent state of the cells.

LncRNA *Gm15055* recruits PRC2 to the *Hoxa* gene cluster in mESC {#SEC4-2}
-----------------------------------------------------------------

PRC2 is a well-recognized key regulator of developmental genes ([@B5]). The most well characterized recruiters of PRC2 are the polycomb repressive elements (PREs) found in *Drosophila melanogaster*, whereas only a few proteins or DNA elements have been identified to guide PRC2 complexes to target genes in mammals ([@B39],[@B40]). LncRNAs have recently been discovered as a new group of mediators for the recruitment of PRC2 to a specific gene locus ([@B8]--[@B10]). Although a panel of lncRNAs have been shown to be capable of interacting with PRC2 in mESCs, only *Gtl2* has been functionally characterized ([@B15]). Our study indicates that the long noncoding RNA *Gm15055* is a new factor for PRC2 recruitment in mESCs. Both knockdown and knockout of *Gm15055* in mESCs significantly decreased PRC2 binding and the H3K27me3 modification at the *Hoxa* gene promoters. Previous work showed that *Gm15055* also recruited PURB ([@B18]). The recent study ([@B29]), however, failed to observe the effect of PUR proteins on *Hoxa* regulation, and indicated the involvement of *Gm15055* in modulating the H3K27me3 at *Hoxa* gene locus in RA-induced ESC. Using a RIP assay, we observed in the present study that *Gm15055* interacted with PRC2 *in vivo* and the BoxB-ChIP analysis further confirmed that *Gm15055* could recruit PRC2 to the adjacent gene locus and facilitate H3K27me3 modification there, suggesting that *Gm15055* recruits PRC2 to the *Hoxa* gene cluster in mESCs. Considering the promiscuous nature that PRC2 exhibited in the recent *in vitro* RNA binding studies ([@B41]--[@B43]), the direct *Gm15055*/PRC2 interaction remains to be determined in the future with more sophisticated approaches.

Our work consistent with the recent study ([@B29]) in finding that *Gm15055* physically close associated with the *Hoxa* gene cluster, which may provide a molecular mechanism for the loading of *Gm15055*-recruited PRC2 to the *Hoxa* genes in mESCs. Instead of using the *Hoxa1* and *Hoxa5* promoters as the 3C leaders as in the previous study, we albeit used the *Gm15055* fragments to screen the *Hoxa* locus, and have identified the active involvement of the +4K, and the *Hoxa7, Hoxa9, Hoxa11* promoters in the association. The chromatin interaction appears relatively stable upon RA induction and after knockdown of the *Gm15055* expression, implying multiple factors like OCT4, CTCF ([@B44]), which has binding sites at both loci, may participate in maintaining the association.

The *Gm15055* locus coordinates the *Hoxa* genes expression {#SEC4-3}
-----------------------------------------------------------

Interpretation of IncRNA function is complexed by the role of RNA per se, the existing of potential regulatory elements in the same locus and even the effect of RNA transcription event ([@B45],[@B46]). By applying the knockdown strategy and establishing differentially knockout clones, recent study and the present work showed unexpected decrease in *Hoxa* genes expression in most of the *Gm15055-*knockout clones, which suggests potential positive *cis-*regulatory elements in the *Gm15055* locus for maintaining a low but responsive *Hoxa* genes expression ([@B29]). Dissection and mutations of the knockout fragment here revealed enhancer activity mainly associated with OCT4 binding sites in the region and that disruption of the OCT4 sites largely impaired this activity. The *cis-*element selectively acted on *Gm15055* and *Hoxa2/4/5/6/7/11* promoters in reporter assay within mESC, and its activity diminished in differentiated MEF cells, emphasized the ESC specificity of the enhancer activity. In addition to this region, bioinformatics analysis using ChIP-seq data of MED12/NIPBL by Kagey *et al*. and that of OCT4/SOX2/NANOG showed enhancer characteristics at multiple sites in the rest part of the *Gm15055* locus (Supplementary Figure S15A-B)([@B25],[@B26],[@B47],[@B48]). The recent study by Yin et al. indicated that knockout to different part of the locus variant in the range of *Hoxa* genes been affected ([@B29]). 3C assay in the present study further showed that different parts of *Gm15055* locus diverse in their affinity to the respective *Hoxa* genes, implying a more differentiated and cooperative mechanism for the *Gm15055* locus and its RNA product to elaborate *Hoxa* gene regulation.

SUPPLEMENTARY DATA {#SEC5}
==================

[Supplementary Data](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkv1315/-/DC1) are available at NAR Online.
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